Caribou Biosciences (CRBU) Stock Price
Caribou Biosciences Price
Revenue has compounded at 11.6% per year over the past 6 years to 11.16 M USD. Caribou Biosciences's net margin stands at -1,327.4%, down from -697.3% several years earlier.
Caribou Biosciences stock price
Caribou Biosciences business model & stock analysis
Frequently asked questions about Caribou Biosciences
13 analysts currently rate the Caribou Biosciences stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Caribou Biosciences to generate revenue of 10.70 M USD and earnings per share of -0.94 USD.
Converted at the current exchange rate, the Caribou Biosciences share trades at 0.44 EUR (0.49 USD).
The Caribou Biosciences share (CRBU) is listed on 1 stock exchanges, including: NASDAQ (CRBU).
The expected revenue of Caribou Biosciences is 10.70 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Caribou Biosciences is -88.56 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Caribou Biosciences is currently -0.52. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Caribou Biosciences stock.
The price-to-sales ratio (P/S) of Caribou Biosciences is currently 4.31. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Caribou Biosciences stock.
The Eulerpool Quality Score for Caribou Biosciences is 2/10.
The ISIN of Caribou Biosciences is US1420381089. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Caribou Biosciences is CRBU. The ticker symbol is used to trade Caribou Biosciences shares on the stock exchange.
Caribou Biosciences stock
Caribou Biosciences Peer Group
Caribou Biosciences Ticker
Caribou Biosciences FIGI
All fundamentals and in-depth analysis of Caribou Biosciences
Our stock analysis for Caribou Biosciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Caribou Biosciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.